PeproTech Recombinant Human M-CSF
- 发布日期: 2025-12-24
- 更新日期: 2025-12-24
产品详请
| 产地 |
|
| 品牌 |
PeproTech
|
| 货号 |
300-25-2UG
|
| 用途 |
重组蛋白
|
| 包装规格 |
/
|
| CAS编号 |
|
| 纯度 |
/%
|
| 是否进口 |
|
产品描述:
M-CSF is a potent hematopoietic factor produced by a variety of cells, including lymphocytes, monocytes, fibroblasts, endothelial cells, myoblasts and osteoblasts. It is a key regulator of cellular proliferation, differentiation, and survival for blood monocytes, tissue macrophages, and their respective progenitor cells. M-CSF has been shown to play important roles in modulating dermal thickness and fertility. M-CSF is clinically used in the treatment of infection, malignancies and atherosclerosis. It facilitates hematopoietic recovery after bone marrow transplantation. Human M-CSF is reactive in murine systems, but the murine molecule exhibits no activity on human cells. Recombinant Human M-CSF is a 36.8 kDa homodimeric protein consisting of two 159 amino acid polypeptide subunits.
来源:E.coli
别名:Macrophage Colony Stimulating Factor, CSF-1, MGI-IM
氨基酸序列:
MEEVSEYCSH MIGSGHLQSL QRLIDSQMET SCQITFEFVD QEQLKDPVCY LKKAFLLVQD IMEDTMRFRD NTPNAIAIVQ LQELSLRLKS CFTKDYEEHD KACVRTFYET PLQLLEKVKN VFNETKNLLD KDWNIFSKNC NNSFAECSSQ GHERQSEGS
纯度:≥ 98% by SDS-PAGE gel and HPLC analyses.
生物活性:The ED50 was determined by the dose-dependent stimulation of the proliferation of murine M-NSF-60 cells ≤ 1 ng/ml, corresponding to a specific activity of ≥ 1 x 106 units/mg.
Calculated Molecular Weight:36.8 kDa
Accession Number:P09603
Gene ID:1435
交叉反应:
Human, Human + Cow, Human + Hamster, Human + Virus, Monkey, Mouse, Rabbit, Rat
原产国: USA
订购信息:
| 300-25-2UG | Recombinant Human M-CSF | 2 ug |
| 300-25-10UG | Recombinant Human M-CSF | 10 ug |
| 300-25-50UG | Recombinant Human M-CSF | 50 ug |
| 300-25-100UG | Recombinant Human M-CSF | 100 ug |
| 300-25-250UG | Recombinant Human M-CSF | 250 ug |
| 300-25-500UG | Recombinant Human M-CSF | 500 ug |
| 300-25-1MG | Recombinant Human M-CSF | 1 mg |
| | | |
| 300-28A-2UG | Recombinant Human SDF-1alpha (CXCL12) | 2 ug |
| 300-28A-10UG | Recombinant Human SDF-1alpha (CXCL12) | 10 ug |
| 300-28A-50UG | Recombinant Human SDF-1alpha (CXCL12) | 50 ug |
| 300-28A-100UG | Recombinant Human SDF-1alpha (CXCL12) | 100 ug |
| 300-28A-250UG | Recombinant Human SDF-1alpha (CXCL12) | 250 ug |
| 300-28A-500UG | Recombinant Human SDF-1alpha (CXCL12) | 500 ug |
| 300-28A-1MG | Recombinant Human SDF-1alpha (CXCL12) | 1 mg |
| | | |
| 300-28B-2UG | Recombinant Human SDF-1beta (CXCL12) | 2 ug |
| 300-28B-10UG | Recombinant Human SDF-1beta (CXCL12) | 10 ug |
| 300-28B-50UG | Recombinant Human SDF-1beta (CXCL12) | 50 ug |
| 300-28B-100UG | Recombinant Human SDF-1beta (CXCL12) | 100 ug |
| 300-28B-250UG | Recombinant Human SDF-1beta (CXCL12) | 250 ug |
| 300-28B-500UG | Recombinant Human SDF-1beta (CXCL12) | 500 ug |
| 300-28B-1MG | Recombinant Human SDF-1beta (CXCL12) | 1 mg |
| | | |
| | | |
| 100-18B-10UG | Recombinant Human FGF-basic (154 a.a.) | 10 ug |
| 100-18B-50UG | Recombinant Human FGF-basic (154 a.a.) | 50 ug |
| 100-18B-100UG | Recombinant Human FGF-basic (154 a.a.) | 100 ug |
| 100-18B-250UG | Recombinant Human FGF-basic (154 a.a.) | 250 ug |
| 100-18B-500UG | Recombinant Human FGF-basic (154 a.a.) | 500 ug |
| 100-18B-1MG | Recombinant Human FGF-basic (154 a.a.) | 1 mg |